Catheter Precision
VTAKCatheter Precision is a medical technology company specializing in the design, manufacture, and sale of innovative solutions for cardiac electrophysiology.
Table of contents
Earnings
Next report
Aug 17, 2026 (In 2 weeks)Competitors
By market cap
By revenue growth
Profile
Catheter Precision is a medical technology company specializing in the design, manufacture, and sale of innovative solutions for cardiac electrophysiology. The company focuses on improving procedural outcomes for cardiac arrhythmias through non-invasive mapping systems and advanced wound closure devices. Its core value proposition centers on reducing procedure time, lowering healthcare costs, and enhancing patient comfort during and after catheter ablation procedures.
Catheter Precision is an emerging player in the EP market, competing against large multinational medical device firms by offering specialized non-invasive mapping and niche vascular closure solutions.
Questions, answered.
- What is Catheter Precision's market cap?
- Catheter Precision (VTAK) has a market capitalization of $1.0M and trades on AMEX.
- Who are Catheter Precision's competitors?
- Catheter Precision's key competitors include Medtronic, Plc., Boston Scientific Corp., Abbott Laboratories, and others. These companies compete in similar markets and product categories.
- Who does Catheter Precision partner with?
- Catheter Precision's notable partners include PEACS, NV, Stereotaxis, Inc., Chelak iECG, Inc..
- What subsidiaries does Catheter Precision have?
- Catheter Precision's subsidiaries include Cardionomix, Inc., KardioNav, Inc..
- Where is Catheter Precision headquartered?
- Catheter Precision is headquartered in United States of America and employs approximately 14 people. It has been publicly traded since 2018.